Study Reveals Greatest Barrier to Green Supply Chain I... ( Companies Strive to Measure ROI...)

Study Reveals Greatest Barrier to Green Supply Chain Initiatives

Date:6/26/2008

Companies Strive to Measure ROI, Balance Business Benefits with

Environmental Responsibility

FALLS CHURCH, Va., and ATLANTA, June 26 /PRNewswire/ -- Companies striving to "green" their supply chains are most constrained by the inability to justify cost of implementation, according to "The Green Supply Chain Study," a new survey jointly conducted by CSC (NYSE: CSC), Manhattan Associates Inc. (Nasdaq: MANH), IBM and Supply Chain Management Review magazine. The study focuses on the most important environmental issues faced by supply chain professionals; outlines the supply chain green initiatives currently implemented or planned in manufacturing, warehousing and distribution; gauges the level of green collaboration with extended supply chain partners; and highlights the greatest challenges for implementing sustainable business practices.

The survey revealed that 78 percent of the 250 supply chain executives who responded are either currently implementing or evaluating sustainable supply chain initiatives. Of those evaluating, close to two-thirds report the greatest barriers their organizations face with regard to establishing these business practices is cost justification. Of those currently implementing a program, 40 percent have not established a method to measure return on investment.

"CSC helped conduct this study to give supply chain executives a view into what strategic green supply chain initiatives are being implemented or planned by their peers and to help them bet
'/>"/>

0

GOOD

Page: 1 2 3
Related biology technology :

1. Results of Study in Pre-School Children Published in Clinical Pediatrics Adds to Support for Importance of Dietary DHA Intake
2. UBC physicists develop impossible technique to study and develop superconductors
3. DNA Study Unlocks Mystery to Diverse Traits in Dogs
4. In a Year of Unprecedented Growth for Biotechnology Innovation, Targeted Therapies Gain Most Significant Traction, According to New Deloitte Study
5. Naviscans PEM Flex(TM) Detects Smallest Cancers Better Compared to MRI in an Independent Study
6. Angiotechs corporate partner, Cook Medical, announces positive interim results for its Zilver(R) PTX(TM) clinical study
7. Cardium Launches New AWARE Clinical Study Website
8. New Study by BioTrends Highlights Practice Management Shifts Among European Nephrologists
9. Peregrine Pharmaceuticals Presents Promising Phase I Data at ASCO and Provides Clinical Update on Its Phase II Bavituximab Breast Cancer Study
10. Clarification on Press Release Issued Earlier Today: Targeted Genetics Confirms Positive, Interim Phase 1/2 Study Findings
11. Genmab Initiates Zalutumumab Combination Study in Colorectal Cancer

Post Your Comments:

Study Reveals Greatest Barrier to Green Supply Chain I...( Companies Strive to Measure ROI...)